Abstract
We have investigated the effect of therapy forHelicobacter pylori gastritis on serum concentrations of pepsinogen I and II in 43 patients. In the 22 patients in whom therapy resulted in dramatic decrease in gastritis scores and in clearance of the bacteria, there was a highly significant (P=0.0001) fall in mean serum pepsinogen II from 13.3±0.8 to 7.9±0.7 μg/liter, and a less pronounced fall in pepsinogen I from 89.0±5.9 to 78.5±0.4 μg/liter (P=0.01). These changes resulted in a significant (P=0.01) increase in the pepsinogen I/II ratio. In contrast, nonsignificant declines of 3.5% and 11.6% were observed in mean pepsinogen I and II levels in the 21 patients whose gastritis failed to resolve histologically and whose infection did not clear. These findings suggest that serum pepsinogen levels, especially pepsinogen II, are a new tool that may be found to be clinically useful in evaluation of treatment outcome in patients withH. pylori-associated gastritis.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Samloff IM, Varis K, Ihamaki T: Determination of gastric mucosal histology by serological and secretory tests. Gastroenterology 80:1269, 1981
Marshall BJ:Campylobacter pyloridis and gastritis. J Infect Dis 153:650–655, 1986
Ruiz B, Janney A, Diavolitsis S, Correa P: One minute test forCampylobacter pylori. Am J Gastroenterol 84:202, 1989
Garvey W, Fathi RT, Bigelow F: Modified Steiner for the demonstration of spirochetes. J Histotechnol 8:15–17, 1985
Correa P: Chronic gastritis: A clinico-pathological classification. Am J Gastroenterol 83:504–509, 1988
Samloff IM: Pepsinogens I and II, purification from gastric mucosa and radioimmunoassay in serum. Gastroenterology 82:26–33, 1982
Spiro HM, Schwartz RD: A cause of temporary achlorhydria and hyperpepsinemia. N Engl J Med 259:682–684, 1958
Samloff IM, Townes PI: Electrophoretic heterogeneity and relationships of pepsinogens in human urine, serum and gastric mucosa. Gastroenterology 58:462, 1970
Samloff IM, Varis K, Ihamaki T, Siurala M, Rotter JI: Relationships among serum pepsinogen I, serum pepsinogen II, and gastric mucosal histology. Gastroenterology 83:204–209, 1982
Samloff IM: Slow moving protease and the seven pepsinogens: Electrophoretic demonstration of the existence of eight proteolytic fractions in human gastric mucosa. Gastroenterology 47:659, 1969
Oderda G, Vaira D, Holton J, Ainley C, Altare F, Boero M, Smith A, Ansaldi N:Helicobacter pylori in children with peptic ulcer and their families. Dig Dis Sci 36:572–576, 1991
Oderda G, Vaira D, Dell'Olio D, Holton J, Forni M, Altare F, Ansaldi N: Serum pepsinogen I and gastrin concentrations in children positive forHelicobacter pylori. J Clin Pathol 43:762–765, 1990
Cave TR, Cave DR:Helicobacter pylori stimulating pepsin secretion from isolated rabbit gastric glands. Scand J Gastroenterol 26(suppl 181):9–14, 1991
Di Napoli A, Boero M, Petrino R, Bellis D, Brossa PC, Chiandussi L: Histological and biochemical modifications afterHelicobacter pylori eradication. Gastroenterology 100:A55, 1991
Truesdale RA, Chamberlain CE, Martin DF, Maydonvvitch CL, Peña S: Serology predicts treatment eradication ofHelicobacter pylori. Gastroenterology 100:A176, 1991
Fraser AG, Prewett EJ, Pounder RE, Samloff IM: Twentyfour hour hyperpepsinogenaemia inHelicobacter pylori-positive subjects is abolished by eradication of the infection. Gastroenterology 102:A70, 1992
Hengels KJ, Jablonowski H, Porschen R, Strohmeyer G: Serum pepsinogen in patients with gastritis and duodenal ulcer disease. Gastroenterology 102:A81, 1992
Plebani M, Delle Fave GF, Annibale B, Stanghellini V, Gasperoni S, Corinaldesi R, DiMario F: Pepsinogens A and C are related toHelicobacter pylori infection. Gastroenterology 102:A148, 1992
Vaira D, Holton J, Cairns SR, Falgon M, Polydorou A, Dowsett JF, Salmon PR: Antibody titres toCampylobacter pylori after treatment for gastritis. BMJ 297:397, 1988
Cutler A, Schubert A, Schubert T:H. pylori serology predicts treatment success. Gastroenterology 102:A53, 1992
Author information
Authors and Affiliations
Additional information
This work was supported by NIH grants P01-CA-28842 and R01-AI-25590.
Rights and permissions
About this article
Cite this article
Hunter, F.M., Correa, P., Fontham, E. et al. Serum pepsinogens as markers of response to therapy forHelicobacter pylori gastritis. Digest Dis Sci 38, 2081–2086 (1993). https://doi.org/10.1007/BF01297088
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01297088